Nasdaq

Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration

FOSTER CITY, Calif. & HAYWARD, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced the closing of Gilead’s option exercises to three ...
Morningstar

Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead’s First Option Target Exercise

“Gilead’s exercise of this first option is a meaningful step in our collaboration and reflects the strength of the targets emerging from our platform,” said Chester Wong, SVP, Head of Business ...
Mississippi State University

Strength through collaboration and preparation: MSU-led Mississippi Cyber Initiative hosts cyber tabletop exercise on healthcare scenarios

STARKVILLE, Miss.—Protection of personal healthcare information is a well-established right for patients, and technology underpins almost every aspect of healthcare operations. A recent cyber tabletop ...
Morningstar

Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration

Opt-out election makes Protagonist eligible for $200 million upon exercise and an additional $200 million upon FDA approval of rusfertide for polycythemia vera Approval would also trigger a $75 ...